Chrisp5, good catch and point. Maybe that is an opportunity for Anavex to clarify (explain and show how the new end point is more relevant and maybe more superior....most importantly...FDA asked for this since that it is the right thing to track and since FDA asked..the approval might be more easier once we meet) this mess officially in a PR.